Immunomic Therapeuticsincis A Clinical Stage Biotechnology Company Based In Hersheypennsylvaniawith Laboratory Facilities In Rockvillemarylandfounded In 2005The Company Specializes In Developing Next Generation Vaccines And Immunotherapies Using Its Proprietary Lamp Vax Platformthis Nucleic Acid Immunotherapy Technology Enhances Immune Responses And Is Designed For Applications In Oncologyallergy Treatmentand Infectious Diseases The Unite Platform Integrates Target Antigens With Lamp To Direct Immune Responsesamplifying Antigen Presentation And T Cell Activationimmunomic Therapeutics Has A Strong Pipeline Focusing On Cancer Vaccinesallergy Therapiesand Infectious Disease Preventionthe Lamp Vax Platform Simplifies Vaccine Designpotentially Reducing Production Costs And Improving Safety Profilesthe Company Has Raised $83 5 Million In Funding And Operates With Around 45 Employeespositioning Itself As An Innovator In The Biotechnology And Pharmaceuticals Sectors
